共 50 条
- [3] Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 22
- [4] A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2016, 8 : 683 - 689
- [6] Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
- [7] A letter to editor - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France." [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 23